Related Experiment Video
Updated: Oct 31, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer Immunotherapy
Huixian Zhang1,2,3, Wencheng Zhao1,2, Xingya Li3
1Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, 200433, People's Republic of China.
Abstract:
Checkpoint-based immunotherapies, such as programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) inhibitors, have shown promising clinical outcomes in many types of cancers. Unfortunately, the response rate of immune checkpoint inhibitors is low. It is very important to discover novel therapeutic targets and prognostic biomarkers. Cholesterol metabolism has been demonstrated to be related to the occurrence and development of a variety of tumors and may provide a new breakthrough in the development of immunotherapy. First of all, cholesterol metabolism in the tumor microenvironment affects the function of tumor-infiltrating immune cells. In addition, intracellular cholesterol homeostasis is an important regulator of immune cell function. Furthermore, drugs that act on cholesterol metabolism affect the efficacy of immunotherapy. What is more, peripheral blood cholesterol level can be a biomarker to predict the efficacy of immunotherapy. In this review, we aimed to explore the potential role of cholesterol metabolism on immunotherapy. By summarizing the major findings of recent preclinical and clinical studies on cholesterol metabolism in immunotherapy, we suggested that cholesterol metabolism could be a potential therapeutic target and a prognostic biomarker for immunotherapy.
Insights
Cholesterol metabolism influences immune cell function and immunotherapy effectiveness. Targeting cholesterol metabolism may improve cancer immunotherapy outcomes and serve as a predictive biomarker.
Area of Science:
- Oncology
- Immunology
- Metabolic Research
Background:
- Immune checkpoint inhibitors (ICIs) like PD-1/PD-L1 blockers show promise in cancer treatment but have low response rates.
- Discovering novel therapeutic targets and prognostic biomarkers is crucial for enhancing ICI efficacy.
- Cholesterol metabolism is increasingly recognized for its role in tumor development and immune response.
Purpose of the Study:
- To explore the potential role of cholesterol metabolism in cancer immunotherapy.
- To review preclinical and clinical findings linking cholesterol metabolism to immunotherapy efficacy.
- To identify cholesterol metabolism as a potential therapeutic target and prognostic biomarker.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of the impact of cholesterol metabolism on tumor microenvironment and immune cells.
- Investigation of drugs targeting cholesterol metabolism and their effect on immunotherapy.
Main Results:
- Cholesterol metabolism significantly affects tumor-infiltrating immune cells and intracellular cholesterol homeostasis.
- Drugs targeting cholesterol metabolism can modulate immunotherapy efficacy.
- Peripheral blood cholesterol levels may serve as a biomarker for predicting immunotherapy response.
Conclusions:
- Cholesterol metabolism plays a critical role in the efficacy of cancer immunotherapy.
- Modulating cholesterol metabolism presents a promising strategy for improving ICI outcomes.
- Cholesterol metabolism warrants further investigation as a therapeutic target and prognostic biomarker in immunotherapy.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

